New CMC Process R&D center will add peptide and oligo-intermediate capabilities, expand analytical and formulation labs and target completion by September 2026. Sai Life Sciences plans to build a 100,000-sq-ft CMC Process R&D center at its integrated R&D campus in Hyderabad, aiming to double its process R&D capacity by September 2026. The project adds dedicated… The post Sai Life Sciences to double process R&D capacity with new Hyderabad facility appeared first on Drug Discovery and Develop...| Drug Discovery and Development